This study examined how clonal hematopoiesis of indeterminate potential (CHIP) remodels the bone marrow (BM) microenvironment, using single-cell transcriptomics, histology, and spatial transcriptomics of freshly isolated BM samples from CHIP patients.
CHIP is marked by fibro-inflammatory BM remodeling: fibroblasts expanded and adopted cancer-associated fibroblast-like states, mesenchymal and vascular cells upregulated collagen and extracellular matrix pathways, and spatial transcriptomics pinpointed discrete fiber-enriched inflammatory hubs enriched for TGF-β and TNF signaling, populated by active and CXCL12+ fibroblasts, macrophages, and lymphoid cells.
The study is cross-sectional and observational, so it cannot establish causality or the temporal sequence of stromal changes relative to clonal expansion; sample size and specific demographic details of the CHIP cohort are not reported in the abstract; generalizability across different CHIP driver mutations is unclear.
Clinicians managing CHIP patients should be aware that prefibrotic stromal changes in the bone marrow may be an early, measurable sign of disease progression toward overt malignancy, potentially warranting closer surveillance for myelofibrosis or hematologic malignancy.